Latest Inflammatory bowel disease Stories
CCFA and University of North Carolina (UNC) Expand IBD Patient-Focused Engagement with CCFA Partners NEW YORK, Feb.
-- Hungarian National Registry reports interim results following Inflectra therapy in 90 patients with Crohn's disease and ulcerative colitis BARCELONA and MADRID, Spain, Feb.
CCFA, AGA and Janssen Biotech Announce New Grant Program NEW YORK, Feb.
NEW YORK, Feb.
NEW YORK, Feb. 2, 2015 /PRNewswire-USNewswire/ -- The number of inflammatory bowel disease (IBD) patients in the U.S.
SANTA BARBARA, Calif., Jan. 29, 2015 /PRNewswire/ -- VG Life Sciences, (VGLS), a biotechnology company developing therapies for autoimmune and infectious diseases, today announced the U.S.
LONDON, January 22, 2015 /PRNewswire/ -- Report Details Treating Crohn's disease and ulcerative colitis - how to find R&D trends, opportunities and revenue
NEW YORK, Jan.
SGM-1019 is an oral small molecule inhibitor of a target identified by company's Microbiome Discovery Platform SOUTH SAN FRANCISCO, Jan.
LONDON, January 7, 2015 /PRNewswire/ -- ~ Shield seeks approval of Feraccru for the treatment of iron deficiency
- A person in a secondary role, specifically the second most important character (after the protagonist).